A Cure in Sight
for Blindness

Retina South Africa is the only patient led advocacy and support group for patients with a wide range of retinal conditions. Our goal is to ensure that all South Africans with these conditions have access to appropriate treatments, and to empower people with low vision to be productive members of society through information-sharing, education, training, and counselling.

LEARN MORE

How We Can Help

Research progress in genetics, stem cells,  artificial vision and other exciting fields are fulfilling the dream of treatments for retinal genetic conditions such as Macular Dystrophies, Stargardt Dystrophy, Retinitis Pigmentosa, Usher Syndrome and Age Related Macular Degeneration, Retina South Africa is dedicated to ensuring access to this dream for all South Africans.

Help line 0860595959 (SA only) or +27114501181

How You Can Help

Become a member.

Learn how you can become a member of our community.

LEARN MORE

Invest in a miracle.

Participate in our fund raising initiatives to help restore the gift of sight.

LEARN MORE

Make a Donation.

Donate now and help us fight blindness.

LEARN MORE

Latest News & Events

Press release graphic announcing the appointment of Manny Moodley as Chief Executive Officer of Retina South Africa. The background features a close-up image of a human eye, with bold text reading: 'PRESS RELEASE – Retina SA Appoints Chief Executive Officer: Manny Moodley.' The Retina South Africa logo and tagline, 'a Cure in Sight for Blindness,' appear in the bottom right corner..
Article category: News .

Article title: A New Chapter Begins at Retina South Africa .

We are pleased to announce the appointment of Manny Moodley (37) as the new Chief Executive Officer of Retina.

LEARN MORE
Cyclists in a competitive road race, wearing helmets and colorful jerseys, participate in the Dis-Chem Ride for Sight event. A large overlay at the bottom of the image showcases various sponsor logos.
Article category: News .

Article title: Dis-Chem Ride for Sight 2025 .

Thank you Dis-Chem Pharmacies for once again sponsoring the 2025 Ride for Sight.- a remarkable unbroken partnership of 17.

LEARN MORE
.
Article category: News .

Article title: Stargardt Disease – At Last .

The first patient has been dosed in the Phase 1/2 ASTRA study for Stargardt disease gene therapy SB-007. SpliceBio from.

LEARN MORE